To study the impact of extending reference pricing incentives to high-cost specialty pharmaceutical classes and physician-administered drugs.
Regents of the University of California at Berkeley
2017 - 2021
Arnold Ventures funds projects to understand problems and identify policy solutions.
Have an evidence-based week
Get The Abstract from Arnold Ventures delivered to your inbox.